Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-009266
Filing Date
2023-03-27
Accepted
2023-03-27 16:28:49
Documents
1
Period of Report
2023-03-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167994891597024.html 4  
1 FORM 4 wf-form4_167994891597024.xml 4 6622
  Complete submission text file 0001628280-23-009266.txt   7940
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
Munk Natalie (Reporting) CIK: 0001932320 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 23764846